Creative Medical Technology Holdings, Inc. (CELZ) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on August 28, 2026. Creative Medical Technology Holdings, Inc., a Nevada corporation, reported the results of a Special Meeting of Stockholders held on this date to approve corporate governance and capital structure amendments.
Key Financial Metrics
This filing is a current report regarding corporate actions and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes and Corporate Actions
- Authorized Share Increase: Stockholders approved an amendment to the Articles of Incorporation increasing authorized common stock from 25,000,000 to 100,000,000 shares.
- Warrant Exercise Approval: Stockholders approved the full exercise of Investor Warrants issued in a June 30, 2026 private placement, covering an aggregate of 5,580,680 shares of common stock.
- Voting Participation: A quorum was established with 3,098,886 shares (65.4% of outstanding shares) present or represented by proxy.
Voting Results
| Proposal | For | Against | Abstain | Broker Non-Votes |
|---|---|---|---|---|
| Proposal I: Share Increase | 2,488,537 | 595,527 | 14,822 | N/A |
| Proposal II: Warrant Exercise | 678,541 | 344,460 | 17,313 | 1,092,794 |
Outlook, Risks, and Management Commentary
The filing does not contain forward-looking guidance, management commentary on financial performance, or specific risk factors beyond the standard disclosures associated with the amendment of corporate charter documents. The Company filed a Certificate of Amendment with the Nevada Secretary of State on August 28, 2026, to effect the share increase.
Key Facts for Investor Verification
- Verify the impact of the 4x increase in authorized shares on potential future dilution.
- Confirm the cash proceeds generated from the full exercise of the 5,580,680 Investor Warrants.
- Review the definitive proxy statement filed on July 14, 2026, for detailed terms of the warrant exercise and the rationale for the share increase.
- Note the significant number of broker non-votes (1,092,794) on the warrant exercise proposal, indicating shares held in street name where brokers lacked discretionary voting power.